Growth Metrics

Novartis Ag (NVS) Retained Earnings (2016 - 2025)

Novartis Ag's Retained Earnings history spans 11 years, with the latest figure at $45.4 billion for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 4.87% to $45.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $45.4 billion, a 4.87% increase, with the full-year FY2025 number at $45.4 billion, up 4.87% from a year prior.
  • Retained Earnings hit $45.4 billion in Q4 2025 for Novartis Ag, up from $41.3 billion in the prior quarter.
  • Over the last five years, Retained Earnings for NVS hit a ceiling of $66.8 billion in Q4 2021 and a floor of $41.0 billion in Q2 2024.
  • Historically, Retained Earnings has averaged $50.9 billion across 5 years, with a median of $48.5 billion in 2023.
  • Biggest five-year swings in Retained Earnings: increased 19.85% in 2021 and later decreased 21.63% in 2023.
  • Tracing NVS's Retained Earnings over 5 years: stood at $66.8 billion in 2021, then decreased by 12.36% to $58.5 billion in 2022, then decreased by 21.63% to $45.9 billion in 2023, then decreased by 5.62% to $43.3 billion in 2024, then increased by 4.87% to $45.4 billion in 2025.
  • Business Quant data shows Retained Earnings for NVS at $45.4 billion in Q4 2025, $41.3 billion in Q2 2025, and $43.3 billion in Q4 2024.